NCT05814133

Thulium Fiber Laser Prospective Trial

Prospective Clinical Trial To Evaluate The Thulium Fiber Laser For The Ureteroscopic Treatment Of Nephrolithiasis
Centre hospitalier de l'Université de Montréal (CHUM)·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Kidney Stone
Drug/Device/Intervention
Thulium Fiber Laser
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Location
Montreal, Canada
Timeline & enrollment
Phase
N/A
Start date
Sep 15, 2023
End date
Jul 15, 2024
Enrollment
150 participants
Primary outcome

Mean total operative time

Summary

This is a multi-center, prospective clinical trial to assess the effect of TFL for the
 lithotripsy of kidney stones.

ICD-10 classifications
Kidney dialysisSmall kidney, unspecifiedDisorder of kidney and ureter, unspecifiedInjury of kidneyUnspecified kidney failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05814133
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05814133 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM) and is currently Not yet recruiting. The study focuses on Kidney Stone. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.